Drug Eluting Stents for Very Long Lesions: Go Long, But Know the Risks. Issue 6 (May 2017)

• Record Type: Journal Article
• Authors: Beale, Charles E.; Dawn Abbott, J.
• Is Part Of: Catheterization and cardiovascular interventions. Volume 89:Issue 6(2017)
• Page Start: 992
• Page End: 993
• Publication Date: 2017-05
• Subjects: Heart -- Diseases -- Diagnosis -- Periodicals; Cardiac catheterization -- Periodicals; 616.1207572
• DOI: 10.1002/ccd.27073
• Languages: English
• ISSNs: 1522-1946

Abstract

Key Points: Long coronary artery lesions are increasingly treated with new technologies including current generation drug eluting stents (DES) despite a lack of robust data on outcomes. In the current study, patients receiving Xience V DES for very long lesions (>35 mm) compared to lesions 25–35 mm had similar outcomes. Future research should address late outcomes, stent thrombosis rates, as well as investigation of lesions greater than 60 mm.